4th Quarter - Report

TCH GROUP, LLC for SANOFI US SERVICES INC (FORMERLY KNOWN AS SANOFI-AVENTIS U S INC )

Firm
Client
Income
$40,000
Expenses
—

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Economics/Economic Development ECN

All provisions of HR 2052 and S 1023 "Global Investment in American Jobs Act of 2013"

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 2052 (113th)

Taxation/Internal Revenue Code TAX

Extension of the U.S. R&D tax credit; extending and maintaining the orphan drug tax credit. Issues related to Corporate Tax Reform.

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Education and awareness of the 2012-2013 influenza season; education and awareness of pandemic and biodefense funding; FDA funding; NIH funding; general issues related to diabetes awareness; H.R.2094 and S.1503; general issues related to School Access to Emergency Epinephrine Act. S.1871 "Sustainable Growth Rate (SGR) Repeal and Medicare Beneficiary Access Improvement Act of 2013." H.R.1024 and S.557 "Medication Therapy Management Empowerment Act of 2013."

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation will benefit.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1503 (113th), H.R. 2094 (113th), S. 557 (113th), H.R. 1024 (113th), S. 1871 (113th)

Medicare/Medicaid MMM

Issues related to changes to the Medicare Part B reimbursement of prescription drugs; issues related to coverage and reimbursement for those who are covered by the Medicaid program and the Medicare program, including the Part D prescription drug benefit; and general issues related to the Medicare Part D program.

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Animals ANI

Education and awareness of issues related to the compunding of medications for animal health; all provisions of HR 1407 "Animal Drug User Fee Amendments of 2013" Education and awareness regarding illegal compounding of veterinary drugs for animals; all provisions of S 622 "Animal Drug and Animal Generic Drug User Fee Reauthorization Act of 2013"

Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.

LobbyistCovered position, as disclosed
JOHN HOLSCLAW —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1407 (113th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.